Research Snapshot: Drs. Malú Gámez Tansey & Oihane Uriarte Huarte
Progranulin loss results in sex-dependent dysregulation of peripheral and central immune system in mice.
Posted in
Chronic Neurological Diseases News
NIH grant expands brain-aging research opportunities for underrepresented students
With new R25 grant, UF neuroscientists offer mentorship and research opportunities to undergraduates interested in cognitive aging and Alzheimer’s disease.
Fruit fly study identifies potential therapeutic target for form of ALS, FTD
UF neuroscientists collaborate on international study revealing a potential therapeutic target for ALS, FTD linked to TDP-43.
Adoptive cellular therapy improves Parkinson’s symptoms in mouse-model study
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
Celine Dion’s diagnosis of stiff-person syndrome brought a rare neurological diagnosis into the public eye – two neurologists explain the science behind it
In The Conversation, Drs. Bhavana Patel and Torge Rempe explain stiff person syndrome, its symptoms, treatment approaches and more.
Parkinson’s disease is more common than thought
Dr. Michael Okun featured in USA Today article about study reporting that the number of Americans with Parkinson’s disease is higher than previously estimated.
UF neuroscientists awarded “Invention of the Year” by UF Innovate
Drs. Coralie de Hemptinne and Jackson Cagle describe their technology designed to identify deep brain stimulation settings based on a patient’s brain activity.
Treatment to strengthen cough shows promise for Parkinson’s patients
Study co-authored by Dr. Karen Hegland found sensorimotor training for airway protection improved cough-related outcomes in Parkinson’s patients.
The future of the aging brain
Dr. Malú Gámez Tansey featured on Flash Forward podcast episode focused on dementia, including diagnosis, treatment and care.
Does replacing dopamine help with facial masking in PD?
Dr. Dawn Bowers and Rachel Schade led study reporting that dopamine medications improves facial movement and expressions in Parkinson’s.
